Protech Home Medical Bundle
Who Owns Protech Home Medical Company?
Understanding a company's ownership is key to grasping its strategy and accountability. Significant ownership shifts, like acquisitions, can profoundly alter a company's path.
Protech Home Medical Corp., now operating as Quipt Home Medical Corp., has undergone significant ownership changes. Its journey began in Alberta, Canada, in 1993, evolving through name changes and a relocation of its corporate office to Kentucky, United States.
Who owns Protech Home Medical Company?
Protech Home Medical Corp. was acquired by AdaptHealth Corp. This acquisition marked a substantial change in its ownership structure. The company, which specialized in advanced respiratory care and sleep solutions, was a North American provider of home medical equipment and services. As of July 2025, the combined entity, Quipt Home Medical Corp., has around 501 employees and reports revenue between $100 million and $1 billion. The integration into AdaptHealth signifies a new chapter for the company's operations and market presence, impacting its approach to patient care and its product offerings, such as those analyzed in the Protech Home Medical BCG Matrix.
Who Founded Protech Home Medical?
Protech Home Medical company's origins trace back to its incorporation as Patient Home Monitoring Corp. on March 5, 1993, in Alberta, Canada. While the specific names of the founders and their initial equity stakes are not publicly detailed, the company's early structure and control distribution remain unclarified in available records.
Original Incorporation
The company was first incorporated as Patient Home Monitoring Corp. on March 5, 1993. This marked the initial establishment of the entity that would later become Protech Home Medical.
Founders and Early Stakeholders
Specific details regarding the founders' identities, their backgrounds, and the initial equity distribution are not readily available. Information on early investors or friends and family who acquired stakes during the inception phase is also not publicly disclosed.
Corporate Relocation
On December 30, 2013, the company underwent a continuation process, moving its incorporation to British Columbia, Canada. This relocation represented a significant administrative change in its corporate structure.
Name Change
A pivotal moment in the company's history occurred on May 4, 2018, when Patient Home Monitoring Corp. officially changed its name to Protech Home Medical Corp. This rebranding reflected a shift in its operational focus or market positioning.
Share Consolidation
In December 2018, the company executed a consolidation of its common shares. This action was performed on a one-for-five basis, meaning every five existing shares were combined into one new share.
Public Trading Commencement
Following the share consolidation, the company's consolidated shares began trading on the TSX Venture Exchange. The stock symbol assigned to Protech Home Medical Corp. for this trading was 'PTQ'.
The early operational and ownership details of Protech Home Medical company, including founder information and initial investment structures, are not extensively documented in public records. The company's evolution involved a significant name change and a share consolidation before commencing trading under the symbol 'PTQ' on the TSX Venture Exchange, indicating its transition towards becoming a publicly recognized entity. Understanding the Mission, Vision & Core Values of Protech Home Medical can provide further context to its early development and strategic direction.
Protech Home Medical SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
How Has Protech Home Medical’s Ownership Changed Over Time?
The ownership of Protech Home Medical Corp. saw a significant shift with its acquisition by AdaptHealth Corp. This move marked a key moment in the company's history, integrating it into a larger national provider of home healthcare solutions.
| Previous Name | New Name | Date of Change |
|---|---|---|
| Patient Home Monitoring Corp. | Protech Home Medical Corp. | May 4, 2018 |
Protech Home Medical Corp. actively engaged in expanding its operations through strategic acquisitions prior to its own acquisition. These acquisitions included Coastal Med Tech Inc. in September 2018, Cooley Medical Equipment, Inc. in October 2019, Acadia Medical, Inc. in December 2019, Riverside Medical, Inc. and Central Oxygen, Inc. in the first fiscal quarter of 2020, and Mayhugh's Medical Equipment in February 2021. These strategic moves illustrate a proactive approach to market consolidation within the home medical equipment sector, aligning with the broader industry trend of larger entities growing their footprint through mergers and acquisitions. Understanding the Growth Strategy of Protech Home Medical provides context for these developments.
AdaptHealth Corp. Ownership Structure
AdaptHealth Corp. is the current parent company of Protech Home Medical. As of July 2025, AdaptHealth is a publicly traded entity on NASDAQ under the ticker AHCO.
- Institutional investors hold 98.36% of AdaptHealth as of July 2025.
- Individual insiders collectively own 100.78% of the company.
- Retail investors hold 0.00% of AdaptHealth.
- Everest Hill Group Inc. is the largest individual shareholder, owning 31.50% (42.51 million shares) valued at approximately $401.26 million as of July 2025.
- Other significant institutional investors include Reinhart Partners LLC, Mutual of America Capital Management LLC, Allianz Asset Management GmbH, New York State Teachers Retirement System, and Vanguard Group Inc.
Protech Home Medical PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
Who Sits on Protech Home Medical’s Board?
Following the acquisition of Protech Home Medical by AdaptHealth Corp., the governance structure now aligns with AdaptHealth's board of directors. Dale Wolf assumed the role of Chair of AdaptHealth's Board of Directors in July 2024, succeeding Richard Barasch. Suzanne Foster, the current Chief Executive Officer of AdaptHealth, joined the Board in May 2024.
| Director Name | Role | Tenure Start |
|---|---|---|
| Dale Wolf | Chair of the Board | November 2019 |
| Suzanne Foster | Chief Executive Officer & Board Member | May 2024 |
| Theodore Lundberg | Independent Director | |
| Gregory Belinfanti | Independent Director | |
| Bradley Coppens | Independent Director | |
| David Williams | Independent Director | |
| Diana Nole | Independent Director | |
| Susan Weaver | Independent Director | |
| Terence Connors | Independent Director |
Josh Parnes concluded his tenure as President on August 31, 2024, and stepped down from the Board of Directors on December 31, 2024. The remaining board members, Theodore Lundberg, Gregory Belinfanti, Bradley Coppens, David Williams, Diana Nole, Susan Weaver, and Terence Connors, are all independent directors. The average tenure for AdaptHealth's board members is approximately 5.1 years, indicating a seasoned leadership team. While specific details on voting power, such as dual-class shares, are not publicly detailed, SEC filings, including beneficial ownership statements, offer insights into insider holdings and their potential influence on voting power, which is crucial for understanding Protech Home Medical ownership post-acquisition.
Understanding Board Dynamics
The composition and tenure of a company's board of directors significantly influence its strategic direction and corporate governance. AdaptHealth's board, with an average tenure of 5.1 years, reflects a blend of experienced leadership and recent additions.
- New leadership appointments can signal strategic shifts.
- Independent directors ensure objective oversight.
- Board tenure impacts institutional knowledge and decision-making.
- Understanding insider holdings is key to assessing voting power.
Protech Home Medical Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
What Recent Changes Have Shaped Protech Home Medical’s Ownership Landscape?
The ownership landscape for the entity formerly known as Protech Home Medical has significantly evolved, now operating under the umbrella of AdaptHealth Corp. This integration marks a key phase in the company's recent history, aligning its operations with a larger, publicly traded healthcare services provider.
| Metric | 2024 (Actual) | 2025 (Projected) |
|---|---|---|
| Net Revenue | $3.26 billion | $3.22 billion - $3.36 billion |
| Adjusted EBITDA | $688.7 million | $670 million - $710 million |
AdaptHealth's strategic direction over the past few years has been characterized by consistent growth and portfolio management. The company reported substantial net revenue for 2024, with projections indicating continued stability into 2025. Recent leadership changes, including the appointment of Suzanne Foster as CEO in May 2024 and Dale Wolf as Chairman of the Board in July 2024, signal a focus on strategic execution and governance within AdaptHealth. The company has also actively managed its asset base, completing the disposition of certain home infusion assets in June 2025. This move, which reduced annual revenue by approximately $52 million, was coupled with significant debt reduction efforts, including a $65 million prepayment on its term loan in June 2025, following a $70 million prepayment in May 2025. These actions underscore a commitment to strengthening the company's financial foundation.
Leadership Evolution
Suzanne Foster assumed the role of CEO in May 2024, bringing new leadership to the organization. Dale Wolf transitioned to Chairman of the Board in July 2024, reinforcing board oversight.
Financial Strategy & Debt Management
AdaptHealth made substantial prepayments on its term loan in May and June 2025, totaling $135 million. These actions, alongside asset dispositions, aim to bolster the company's balance sheet.
Strategic Focus Areas
Initiatives for the latter half of 2024 and into 2025 include accelerating AI and automation, enhancing clinical relevance, and driving organic growth. The company is also prioritizing strengthening its balance sheet.
Industry and Ownership Trends
The home medical equipment sector continues to see M&A activity, driven by technological advancements and a push for integrated care models. As of July 2025, institutional investors held 98.36% of AdaptHealth's stock, indicating significant public market ownership. For a deeper understanding of the company's journey, refer to the Brief History of Protech Home Medical.
Protech Home Medical Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
- What is Brief History of Protech Home Medical Company?
- What is Competitive Landscape of Protech Home Medical Company?
- What is Growth Strategy and Future Prospects of Protech Home Medical Company?
- How Does Protech Home Medical Company Work?
- What is Sales and Marketing Strategy of Protech Home Medical Company?
- What are Mission Vision & Core Values of Protech Home Medical Company?
- What is Customer Demographics and Target Market of Protech Home Medical Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.